Description
Articles de périodiques scientifiques
Général
- Health disparities in cystic fibrosis in the context of the exposome: recent developments and future directionson 17 juin 2026
Expert Rev Respir Med. 2026 May 23. doi: 10.1080/17476348.2026.2679780. Online ahead of print.ABSTRACTINTRODUCTION: Clinical outcomes with cystic fibrosis (CF) vary substantially even among […]
- Mental Health in Cystic Fibrosis in the Modulator Era: Epidemiology, Prognostic Significance, and Therapeutic Implicationson 17 juin 2026
J Clin Med. 2026 May 20;15(10):3953. doi: 10.3390/jcm15103953.ABSTRACTIndividuals with cystic fibrosis (CF) face significant treatment burdens, and as life expectancy has increased, there is growing […]
- Cystic Fibrosis-Associated Inflammatory Bowel Disease: a Case Series and Literature Reviewon 17 juin 2026
Clin Res Hepatol Gastroenterol. 2026 Jun 12:102867. doi: 10.1016/j.clinre.2026.102867. Online ahead of print.ABSTRACTINTRODUCTION: The management of inflammatory bowel disease (IBD) in patients with […]
- Deep Optic Nerve Head Structural Alterations in Adults with Cystic Fibrosison 17 juin 2026
J Clin Med. 2026 Jun 2;15(11):4308. doi: 10.3390/jcm15114308.ABSTRACTBackground: Cystic fibrosis (CF) is a systemic genetic disorder characterized by chronic inflammation, hypoxia, and metabolic […]
- Economic evaluation of CFTR modulator therapies in cystic fibrosis: a cost-benefit and cost-effectiveness perspective from the REMEDIA European commission projecton 17 juin 2026
J Cyst Fibros. 2026 May 26:S1569-1993(26)00134-7. doi: 10.1016/j.jcf.2026.05.011. Online ahead of print.ABSTRACTBACKGROUND: Cystic fibrosis (CF) is a rare, life-limiting genetic disorder […]
- Risk factors for longitudinal estimated glomerular filtration rate decline in adults with cystic fibrosis.on 16 juin 2026
Annals of the American Thoracic Society; 05/01/2026(AN 193780615); ISSN: 23296933CINAHL Complete
- Renal function decline in adults with cystic fibrosis experiencing pulmonary exacerbations.on 16 juin 2026
Annals of the American Thoracic Society; 05/01/2026(AN 193780648); ISSN: 23296933CINAHL Complete
- Clinical characteristics and outcomes in the adult cystic fibrosis population in Europe from 2014 to 2024: analysis of the European Cystic Fibrosis Society Patient Registryon 16 juin 2026
Lancet Respir Med. 2026 Jun 3:S2213-2600(26)00149-9. doi: 10.1016/S2213-2600(26)00149-9. Online ahead of print.ABSTRACTBACKGROUND: Since 2018, important advancements in the medical care of people […]
- Genotoxic pks + E. coli is strongly associated with ileocolonic neoplasia in adults with Cystic Fibrosison 16 juin 2026
J Cyst Fibros. 2026 Jun 5:S1569-1993(26)01639-5. doi: 10.1016/j.jcf.2026.05.016. Online ahead of print.ABSTRACTBACKGROUND: Polyketide synthase island-positive (pks+) Escherichia coli is a genotoxic […]
- Cystic Fibrosis-Asthma Overlap Syndrome: Current Understanding and Future Directionson 16 juin 2026
Pediatr Pulmonol. 2026 Jun;61(6):e71682. doi: 10.1002/ppul.71682.ABSTRACTBACKGROUND: Cystic fibrosis-asthmaoverlap syndrome (CFAOS) has high incidence in people with CF (pwCF) yet remains poorly […]
Diagnostic et évaluation
- Assessing the Need for Reproductive Genetic Counseling Among Adults with Cystic Fibrosison 16 juin 2026
Res Sq [Preprint]. 2026 May 11:rs.3.rs-9227324. doi: 10.21203/rs.3.rs-9227324/v1.ABSTRACTBackground Reproductive health has become an increasingly important focus for people with cystic fibrosis […]
- What Parents Need to Know About Screening for Cystic Fibrosis in Newbornson 16 juin 2026
JAMA Pediatr. 2026 May 26. doi: 10.1001/jamapediatrics.2026.1812. Online ahead of print.NO ABSTRACTPMID:42189566 | DOI:10.1001/jamapediatrics.2026.1812
- 3D-printed solid-contact chloride sensor for sweat-based cystic fibrosis screeningon 16 juin 2026
Biosens Bioelectron. 2026 May 26;310:118831. doi: 10.1016/j.bios.2026.118831. Online ahead of print.ABSTRACTCystic fibrosis (CF) is a genetic disorder marked by impaired chloride transport, with […]
- Radiologic progression with minimal functional decline in cystic fibrosis: Insights from a prospective studyon 16 juin 2026
World J Radiol. 2026 May 28;18(5):117936. doi: 10.4329/wjr.v18.i5.117936.ABSTRACTBACKGROUND: Timely identification and monitoring of lung disease progression are key components of effective […]
- Toward Precision Electrochemical Sensing of CFTR Function in Cystic Fibrosis Modelson 16 juin 2026
Anal Chem. 2026 Jun 4. doi: 10.1021/acs.analchem.6c00392. Online ahead of print.ABSTRACTThe assessment of cystic fibrosis transmembrane conductance regulator (CFTR) activity is essential to both […]
- The Diagnostic Complexities of Cystic Fibrosis: When to Think of It and What to Do?on 16 juin 2026
Br J Hosp Med (Lond). 2026 May 20;87(5):54065. doi: 10.31083/BJHM54065.ABSTRACTCystic fibrosis (CF) is one of the most common life-shortening hereditary disorders, caused by a defect in the cystic […]
- A multi-center study of non-invasive colorectal cancer evaluation in cystic fibrosis (NICE-CF)on 16 juin 2026
J Cyst Fibros. 2026 Jun 5:S1569-1993(26)01640-1. doi: 10.1016/j.jcf.2026.05.017. Online ahead of print.ABSTRACTBACKGROUND: People with Cystic Fibrosis (PwCF) have a higher risk of digestive cancers […]
Interventions et traitements
- Effect of discontinuation and reduction of respiratory cotherapies on the effectiveness of CFTR modulatorson 17 juin 2026
J Cyst Fibros. 2026 May 20:S1569-1993(26)00113-X. doi: 10.1016/j.jcf.2026.05.007. Online ahead of print.ABSTRACTBACKGROUND: We evaluated whether the initiation of CFTR modulators led to a concomitant […]
- A functional comparison of vanzacaftor/tezacaftor/deutivacaftor and elexacaftor/tezacaftor/ivacaftor in patient-derived intestinal organoids with rare CFTR variantson 17 juin 2026
J Cyst Fibros. 2026 Jun 16:S1569-1993(26)01643-7. doi: 10.1016/j.jcf.2026.06.002. Online ahead of print.ABSTRACTBACKGROUND: Cystic fibrosis (CF) results from pathogenic CFTR variants that impair […]
- Remodeling the pathological airway: advanced nanotechnology for diagnostics and therapeutics in cystic fibrosison 16 juin 2026
J Nanobiotechnology. 2026 Jun 16. doi: 10.1186/s12951-026-04689-4. Online ahead of print.ABSTRACTCystic fibrosis (CF) constitutes a prototypical lethal genetic disorder characterized by profound […]
- Lumacaftor–Ivacaftor in Pediatric Patients With Cystic Fibrosis and Advanced Liver Disease: A Pilot Study.on 16 juin 2026
Clinical Therapeutics; 06/01/2026(AN 193888564); ISSN: 01492918CINAHL Complete
- Study Design Considerations for the Evaluation of Pancreatic Enzyme Replacement Therapy (PERT) Products in People with Cystic Fibrosis: An Update.on 16 juin 2026
Clinical Therapeutics; 07/01/2026(AN 194525806); ISSN: 01492918CINAHL Complete
- Comparison of Long Term Effects of Treatment of Different CFTR Modulators in People With Cystic Fibrosison 16 juin 2026
Pediatr Pulmonol. 2026 Jun;61(6):e71681. doi: 10.1002/ppul.71681.ABSTRACTBACKGROUND: Cystic fibrosis transmembrane conductance regulator modulators (CFTRm) represent a breakthrough in the treatment […]
- Real-World Clinical Outcomes of Lumacaftor-Ivacaftor or Tezacaftor-Ivacaftor Therapy in Children With Cystic Fibrosis Homozygous for Phe508delon 16 juin 2026
Pediatr Pulmonol. 2026 Jun;61(6):e71701. doi: 10.1002/ppul.71701.ABSTRACTBACKGROUND: Cystic fibrosis (CF) is a progressive, life-shortening disease caused by mutations in the cystic fibrosis […]
- Real-Life Experience With a Generic Formulation of Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis With Responding Variantson 16 juin 2026
Pediatr Pulmonol. 2026 Jun;61(6):e71706. doi: 10.1002/ppul.71706.ABSTRACTINTRODUCTION: Elexacaftor/Tezacaftor/Ivacaftor (ETI) has revolutionized cystic fibrosis (CF) care. In Argentina, the absence […]
Transplantation
- Pulmonary Hypertension Prevalence and Significance in Lung Transplant Recipients With Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis.on 16 juin 2026
CHEST; 06/01/2026(AN 194044854); ISSN: 00123692CINAHL Complete
- Lung transplant in people with cystic fibrosis and nontuberculous mycobacteria infectionon 11 mai 2026
Cochrane Database Syst Rev. 2026 Apr 21;4:CD016200. doi: 10.1002/14651858.CD016200.ABSTRACTRATIONALE: Cystic fibrosis (CF) is an inherited multi-organ disorder. People with CF (pwCF) experience […]
- A Deep Dive into Endocrine and Reproductive Health in Patients with Cystic Fibrosis: Before and Beyond Solid Organ Transplantationson 11 mai 2026
Endocr Pract. 2026 Apr 20:S1530-891X(26)00953-5. doi: 10.1016/j.eprac.2026.04.006. Online ahead of print.ABSTRACTPatients with cystic fibrosis (pwCF) often have significant baseline endocrine […]
Mode de vie et approches complémentaires
- One year follow-up of physical activity and health-related quality of life in youth with Cystic Fibrosis in the modulator eraon 16 juin 2026
Sci Rep. 2026 May 27. doi: 10.1038/s41598-026-54693-9. Online ahead of print.ABSTRACTElexacaftor/Tezacaftor/Ivacaftor (ETI) has led to major pulmonary and nutritional benefits in youth with cystic […]
- Interrelationships among handgrip strength, body composition, physical activity, and quality of life in adults with cystic fibrosis: A cross‐sectional study.on 16 juin 2026
Nutrition in Clinical Practice; 06/01/2026Background: In individuals with cystic fibrosis (CF), lean mass and muscle strength are important predictors of clinical outcomes. This study evaluated […]
- Digestibility and microbiota modulation by nuts and sunflower seeds in cystic fibrosis: an in vitro approach.on 16 juin 2026
European Journal of Nutrition; 06/01/2026Purpose: This study evaluated the lipid and protein digestibility and the prebiotic potential of almonds, hazelnuts, peanuts, and sunflower seeds through […]
- Psychological well-being in adults with cystic fibrosis during pregnancy and parenthood: A systematic reviewon 16 juin 2026
J Health Psychol. 2026 May 19:13591053261446886. doi: 10.1177/13591053261446886. Online ahead of print.ABSTRACTCystic fibrosis is a genetic condition affecting multiple organ systems, and advances in […]
- The Impact of Exercise Intervention on Pulmonary and Physical Function in Patients With Cystic Fibrosis: A Comprehensive Systematic Reviewon 16 juin 2026
Saudi Med J. 2026 Jul;47(7):1105-1114. doi: 10.15537/1658-3175.8798. Epub 2026 Jun 8.ABSTRACTOBJECTIVE: To evaluate the effect of various exercise interventions on lung function, specifically forced […]
- A Qualitative Study of the Lived Experiences and Needs of Parent Caregivers of People With Cystic Fibrosison 16 juin 2026
Pediatr Pulmonol. 2026 Jun;61(6):e71703. doi: 10.1002/ppul.71703.ABSTRACTBACKGROUND: Approximately 1500 children in Canada are diagnosed with cystic fibrosis (CF). A childhood CF diagnosis has […]
Expériences des patients et des institutions
- People with Cystic Fibrosis' Experience of Symptom Burden While Taking Elexacaftor/ Tezacaftor/ Ivacaftoron 17 juin 2026
Respir Med. 2026 May 27:108908. doi: 10.1016/j.rmed.2026.108908. Online ahead of print.ABSTRACTBACKGROUND: Despite improvements seen with elexacaftor/tezacaftor/ivacaftor (ETI), many people with CF […]
- A feasibility pilot trial to deliver a virtual intervention for promoting daily self-management in adolescents and young adults with cystic fibrosis: A brief report of tele-coach outcomeson 17 juin 2026
PEC Innov. 2026 Jun 1;9:100481. doi: 10.1016/j.pecinn.2026.100481. eCollection 2026 Dec.ABSTRACTOBJECTIVE: Cystic fibrosis (CF) is a chronic disease that requires intensive daily self-management. […]
- A Qualitative Study on the Experiences and Perspectives of Adults with Cystic Fibrosis and Healthcare Professionalson 17 juin 2026
Respir Med. 2026 Jun 15:108963. doi: 10.1016/j.rmed.2026.108963. Online ahead of print.ABSTRACTBACKGROUND: Cystic fibrosis (CF) is a multisystemic disease increasingly affecting adults due to […]
- Telehealth by Home Monitoring and Video Consultation for Children With Cystic Fibrosis: Qualitative and Quantitative Studyon 16 juin 2026
JMIR Form Res. 2026 May 26;10:e80722. doi: 10.2196/80722.ABSTRACTBACKGROUND: Clinical outcomes for patients with cystic fibrosis have improved over the last decades, with a focus on enhancing the […]
- 'The Hero's journey': Narratives on the transition to motherhood with cystic fibrosis.on 16 juin 2026
British Journal of Health Psychology; 05/01/2026(AN 194051799); ISSN: 1359107XCINAHL Complete
- Clinical Use of Home Spirometry in Children With Cystic Fibrosison 16 juin 2026
Pediatr Pulmonol. 2026 Jun;61(6):e71691. doi: 10.1002/ppul.71691.ABSTRACTBACKGROUND: The use of home spirometry (HSPIR) has increased in pediatric cystic fibrosis (CF) care, but how it has been used […]
- Reporting of Telehealth Implementation in Cystic Fibrosis: Scoping Review Using a Novel Theory-Based Evaluation Lenson 16 juin 2026
J Med Internet Res. 2026 May 22;28:e86194. doi: 10.2196/86194.ABSTRACTBACKGROUND: Many inductive reviews exploring telehealth and its application in health care have identified missing or […]
Pour obtenir les documents
L’accès au texte intégral des documents est restreint au personnel et aux médecins du CHUM en fonction des abonnements de la bibliothèque. Certains documents sont en accès libre sur le web.
Si vous êtes branchés sur le réseau CHUM :
Cliquer sur les liens fournis pour chaque référence pour vérifier la disponibilité du texte intégral.
Pour les articles provenant de PubMed, cliquer préalablement sur le lien suivant pour afficher la disponibilité du document.
Si vous êtes dans un autre établissement et que vous n’arrivez pas à accéder au texte intégral d’un article à partir du lien donné, vérifier auprès de la bibliothèque de votre institution en donnant la référence complète du document.
|
Avis de non-responsabilité
Le contenu des veilles informationnelles ou stratégiques (ci-après appelée « Veilles ») est mis à votre disposition à titre informatif pour un usage personnel exclusif. Tout usage commercial du contenu des Veilles est strictement interdit. Tous les éléments, articles, rapports ou toute autre source d’information figurant dans les Veilles, vous sont fournis « tels quels », sans garantie d’aucune sorte. Eu égard aux propos tenus dans les articles et les rapports sélectionnés pour les Veilles, le CHUM n’offre aucune garantie notamment d’exhaustivité, de fiabilité, d’actualité et d’exactitude.Le CHUM ne pourra en aucun cas être tenu responsable envers quiconque de tout dommage quel qu’il soit, même ceux directs, encouru notamment des suites de toute réclamation, action ou poursuite découlant, même directement, de l’utilisation de ces Veilles.
Les Veilles contiennent des liens vers des sites Web créés et mis à jour par des tierces parties. Ces liens sont fournis pour la commodité des utilisateurs seulement. Le CHUM n’endosse et ne garantit, ni explicitement ni implicitement, l’exactitude ou l’intégralité ni du contenu de ces hyperliens ni des opinions qui y sont exprimées. Le CHUM n’assume aucune responsabilité à l’égard de ces sites Web externes.
Le CHUM prend tous les moyens raisonnables afin de respecter les droits de propriété intellectuelle afférents au contenu des Veilles et aux modalités du prêt entre bibliothèques, émises par l’Université de Montréal. Le contenu des Veilles, incluant la manière dont il est présenté, sont notamment protégés par la Loi sur le droit d’auteur (L.R.C. (1985), ch. C-42). Le CHUM ne donne aucune garantie et ne fait aucune déclaration à l’effet que le contenu de ces veilles n’enfreint aucun droit d’une autre personne ou entité. Le téléchargement, la reproduction en un seul exemplaire ou le tirage sur papier des Veilles ne sont autorisés qu’à des fins de sauvegarde et pour un usage privé et non commercial. Tout téléchargement, reproduction, édition, diffusion sur Internet, utilisation à des fins commerciales ou publiques, distribution, publication sur un autre site ou sur quelque autre forme ainsi que toute autre utilisation est strictement interdite, à moins d’être faite dans le respect des règles de propriété intellectuelle applicables. |


